MELBOURNE, AUSTRALIA--(Marketwire - July 08, 2008) - Rudolph E. Tanzi, Ph.D., Co-Founding Scientist of Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, was invited this past May to testify in front of the U.S. Senate Special Committee on Aging on the Future of Alzheimer’s: Breakthroughs and Challenges. The hearing, lead by Senator Herb Kohl (D-WI) and Senator Gordon H. Smith (R-OR), discussed Alzheimer’s Disease as a growing crisis and how the United States can accelerate its efforts against the disease. Additional participants included Sandra Day O’Connor, Former Supreme Court Justice, Member of the Alzheimer’s Study Group, Newt Gingrich, Former Speaker of the House of Representatives, Member of the Alzheimer’s Study Group, Charles Jackson, Alzheimer’s patient and Suzanne Carabone, Alzheimer’s patient caregiver.
